Publications by authors named "Braydon Alaimo"

Claim this Profile
T
Therapeutic potential of the latest oxygen affinity-modifying agent, GBT021601, for treating sickle cell disease is questionable.
Braydon Alaimo, Belhu Metaferia, Troy Cellmer, Swee Lay Thein, H Franklin Bunn

Br J Haematolยท December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis